Philip Tipton

Updates on anti-amyloid monoclonal antibodies for AD in Phase III trials 3:49
Updates on anti-amyloid monoclonal antibodies for AD in Phase III trials
Philip Tipton • 27 Apr 2023
Use of AD blood-based biomarkers for trial enrolment 4:01
Use of AD blood-based biomarkers for trial enrolment
Philip Tipton • 27 Apr 2023
Expanding research into biomarkers for RPD differentiation 1:19
Expanding research into biomarkers for RPD differentiation
Philip Tipton • 27 Apr 2023
A practical approach to cognitive impairment management 2:39
A practical approach to cognitive impairment management
Philip Tipton • 3 Apr 2022
Important developments in dementia: biomarkers & clinical trials 4:52
Important developments in dementia: biomarkers & clinical trials
Philip Tipton • 3 Apr 2022
Targeting β-amyloid and tau in Alzheimer’s disease 3:11
Targeting β-amyloid and tau in Alzheimer’s disease
Philip Tipton • 3 Apr 2022
The content of VJDementia is intended for healthcare professionals